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Objectives. We sought to compare myocardial contrast echocar-
diography with low dose dobutamine echocardiography for pre-
dicting 1-month recovery of ventricular function in acute myocar-
dial infarction treated with primary coronary angioplasty.
Background. The relation between myocardial perfusion and
contractile reserve in patients with acute myocardial infarction, in
whom anterograde ﬂow is fully restored without signiﬁcant resid-
ual stenosis, is still unclear.
Methods. Thirty patients with acute myocardial infarction
treated successfully with primary coronary angioplasty underwent
intracoronary contrast echocardiography before and after angio-
plasty and dobutamine echocardiography 3 days after the index
infarction. One month later, two-dimensional echocardiography
and coronary angiography were repeated in all patients and
contrast echocardiography in 18 patients.
Results. After coronary recanalization, 26 patients showed
myocardial reperfusion within the risk area, although 4 did not.
At 1-month follow-up, all patients had a patent infarct-related
artery without signiﬁcant restenosis. Both left ventricular ejection
fraction and wall motion score index within the risk area signif-
icantly improved in the patients with reperfusion ([mean  SD]
38  8% vs. 48  12%, p < 0.005; and 2.35  0.5 vs. 2  0.6, p <
0.001, respectively), but not in those with no reﬂow. Of the 72
nonperfused segments before angioplasty, 27 showed functional
improvement at follow-up. Myocardial contrast echocardiography
had a sensitivity and a negative predictive value similar to
dobutamine echocardiography in predicting late functional recov-
ery (96% vs. 89% and 89% vs. 93%, respectively), but a lower
speciﬁcity (18% vs. 91%, p < 0.001), positive predictive value (41%
vs. 86%, p < 0.001) and overall accuracy (47% vs. 90%, p < 0.001).
Conclusions. Microvascular integrity is a prerequisite for myo-
cardial viability after acute myocardial infarction. However, con-
trast enhancement shortly after recanalization does not necessar-
ily imply a late functional improvement. Thus, contractile reserve
elicited by low dose dobutamine is a more accurate predictor of
regional functional recovery after reperfused acute myocardial
infarction than microvascular integrity.
(J Am Coll Cardiol 1996;28:1677–83)
1996 by the American College of Cardiology
It is well known that early restoration of anterograde ﬂow in
patients with acute myocardial infarction can limit the progres-
sion of myocardial necrosis and should enhance the functional
recovery of postischemic dysfunctioning myocardium (1–3).
Clinical methods to predict left ventricular functional recovery
after reperfusion have focused on contractile reserve, myocar-
dial perfusion or metabolic activity (4). Recently both contrac-
tile reserve during dobutamine infusion and myocardial perfu-
sion by myocardial contrast echocardiography have been used
to predict recovery of regional myocardial function in patients
with acute myocardial infarction. In the postinfarction reper-
fused myocardium, the degree of contractile reserve elicited by
dobutamine echocardiography provides a reliable assessment
of the extent of viable myocardium (5–8), especially in the
absence of residual stenosis limiting hyperemic ﬂow (9). In
contrast, myocardial contrast echocardiography is a validated
technique for assessing the spatial distribution of microvascu-
lar perfusion, and recent studies have demonstrated that
microvascular integrity is closely associated with myocardial
cellular viability after acute myocardial infarction in humans
(10–13). However, the relation between microvascular integ-
rity and inotropic reserve of reperfused postischemic dysfunc-
tioning myocardial segments is still unclear. These two aspects
of viability may in fact provide different information regarding
functional recovery after reperfusion, and it is not known
which of them is more accurate in this setting. Thus, the aim of
this study was to compare dobutamine echocardiography and
myocardial contrast echocardiography in predicting 1-month
functional recovery of regional ventricular function in patients
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with acute myocardial infarction treated with successful pri-
mary percutaneous transluminal coronary angioplasty.
Methods
Patients and study protocol. We prospectively compared
dobutamine echocardiography with myocardial contrast echo-
cardiography in 37 patients with acute myocardial infarction
selected among 121 patients referred to the catheterization
laboratory of the Division of Cardiology of Careggi Hospital
for emergency primary coronary angioplasty between January
1995 and December 1995. The study inclusion criteria were: 1)
symptoms of acute myocardial infarction that persisted for
longer than 30 min associated with an elevation 0.1 mV in
the ST segment in two or more contiguous electrocardio-
graphic (ECG) leads; 2) presentation within 6 h after the onset
of symptoms or between 6 and 24 h if there was evidence of
continuing ischemia; 3) total occlusion of the infarct-related
artery; and 4) successful primary coronary angioplasty (deﬁned
as Thrombolysis in Myocardial Infarction [TIMI] ﬂow grade 3
and residual stenosis 30%). Exclusion criteria included the
presence of either cardiogenic shock or evident clinical insta-
bility. No upper age limit was used. Seven (18%) of 37 patients
were excluded from the analysis because of either inadequate
image quality on the echocardiogram recorded in the cathe-
terization laboratory (four patients) or insufﬁcient contrast
effect (three patients). Thus, 30 patients (23 men, 7 women,
mean age 60  11 [range 36 to 83]) were enrolled in the study.
The research protocol was approved by the local ethics com-
mittee, and informed consent was obtained from each patient
by one of the investigators (L.B.).
Myocardial contrast echocardiography was performed dur-
ing acute coronary occlusion, on completion of diagnostic
coronary angiography and contrast left ventriculography, and
was repeated shortly after coronary angioplasty. Low dose
dobutamine echocardiography was performed at a mean of 3
days (range 2 to 5) after admission. Two-dimensional echocar-
diography and coronary angiography were obtained in all
patients, and myocardial contrast echocardiography was re-
peated in 18 patients 1 month after primary coronary angio-
plasty.
Myocardial contrast echocardiography. Patients were
studied in the supine position. Myocardial contrast echocardi-
ography was performed by injecting 3 ml of iopamidol (Io-
pamiro, Bracco SpA, Italy), hand-agitated during its passage
through a three-way stopcock (14,15), followed by a 3-ml saline
ﬂush into the left main and right coronary artery ostia through
standard angiographic coronary catheters. In six patients with
an occluded left anterior descending coronary artery, contrast
injection was performed only in the left main ostium. Echo-
cardiographic images were generated by commercially avail-
able imaging systems (Aloka model SSD-830 2.5- and 3.5-MHz
transducers and Hewlett-Packard Sonos 2500 2.5-MHz trans-
ducer). In each patient the standard echocardiographic view
delineating the most asynergic walls was chosen; speciﬁcally,
the apical four-chamber view was selected in 5 patients, the
ﬁve-chamber view in 21, the two-chamber view in 2 and the
parasternal short-axis view in 2. The gain setting controls were
adjusted at the beginning of each study and kept unchanged
throughout the study. Echocardiographic images were re-
corded from before the injection up to 3 min later by a 0.5-in.
VHS videotape recorder (Panasonic NV 410). After coronary
angioplasty, ultrasound contrast material was injected into the
recanalized infarct-related artery using the same echocardio-
graphic view. A 12-lead ECG was continuously monitored
during the procedure.
Dobutamine echocardiography. Patients underwent dobut-
amine echocardiography at a mean of 3 days (range 2 to 5)
after the onset of myocardial infarction, while taking all
prescribed medications. Echocardiograms were obtained by a
commercially available electrical sector scanner (Aloka model
SSD 870) equipped with 2.5- and 3.5-MHz transducers. Al-
though all standard views were acquired and recorded, the
initial myocardial contrast echocardiographic images were
reviewed before each echocardiographic study to depict the
same echocardiographic view as best as possible. Images were
displayed in real time and were recorded on a videotape by a
0.5-in. VHS cassette recorder (Sony SVO-140PA).
During continuous ECG and two-dimensional echocardio-
graphic monitoring, an intravenous infusion of dobutamine (5
g/kg body weight per min) was started with an infusion pump
and continued for 5 min and then increased to 10 g/kg per
min for another 5 min. The criteria for stopping dobutamine
infusion included hypotension, angina and signiﬁcant ventric-
ular arrhythmias.
Data analysis. Two-dimensional contrast echocardiographic
images were analyzed by three readers (D.R., P.B., L.B.) who
had no knowledge of the clinical and angiographic data. The
left ventricle was divided according to a 16-segment model
(16). In each segment myocardial contrast echocardiographic
effect was scored as 0 (no visible contrast effect), 0.5 (patchy
myocardial contrast enhancement or opaciﬁcation of the epi-
cardial layer only) or 1 (homogeneous contrast effect) (12).
When there was a disagreement about the results, the majority
judgment was binding. The echocardiographic view delineating
the most asynergic walls was chosen for contrast echocardio-
graphic analysis. In this view the risk area was deﬁned as an
area not showing contrast enhancement (score 0) and was
determined in the postinjection cycles showing the best delin-
eation between contrast-enhanced and nonenhanced myocar-
dium. A score of 0.5 or 1 within the area at risk after
Abbreviations and Acronyms
ANOVA  analysis of variance
df  degrees of freedom
ECG  electrocardiogram, electrocardiographic
TIMI  Thrombolysis in Myocardial Infarction
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angioplasty was interpreted as reperfusion. A patient was
considered to have adequate reperfusion if 50% of segments
within the area at risk were opaciﬁed on myocardial contrast
echocardiography.
Dobutamine echocardiograms were analyzed by two readers
(G.C., C.M.) blinded to clinical, angiographic and myocardial
contrast echocardiographic data. Discrepancies were resolved
by consensus. Regional wall motion was assessed according to
the same 16-segment model used for contrast echocardiogra-
phy. For each segment wall motion was scored as 1 (normal),
2 (hypokinetic), 3 (akinetic) or 4 (dyskinetic). In evaluating
regional wall motion abnormalities, attention was also paid to
the systolic thickening in the central portion of each segment.
In each patient both a global and an area at risk wall motion
score index were derived. The latter was obtained by averaging
the scores from each segment within the area at risk. A single
myocardial segment within the area at risk was considered
responsive to dobutamine echocardiography if the wall motion
score decreased by at least one grade during any stage of the
dobutamine infusion compared with the baseline study. A patient
was considered improved on dobutamine echocardiography if
wall motion improved in two or more contiguous segments.
When performing follow-up echocardiography, again, par-
ticular attention was paid to obtain the same echocardio-
graphic view selected during contrast and dobutamine echo-
cardiography. Late reversible dysfunction was deﬁned as
improved wall motion (a reduction in segmental score of at
least one grade) at late follow-up compared with the baseline
study. The left ventricular ejection fraction was calculated
according to the area-length method.
All angiograms were analyzed by two experienced observers
(D.A., L.B.) blinded to myocardial contrast and dobutamine
echocardiographic results. Discrepancies were resolved by
consensus. The infarct-related artery was analyzed using a
quantitative, computer-assisted, edge-detection system (Sie-
mens Hicor II), which compared the stenotic segment deﬁned
by the observer with a “normal” segment deﬁned in the same
vessel, and expressed the result as percent stenosis. In all
patients the infarct-related artery was analyzed both before
and after primary coronary angioplasty to assess residual
stenosis. Contrast ﬂow through the epicardial vessel was
graded using the standard TIMI trial ﬂow scale of 0 to 3 (17).
The same views of coronary arteries were used at follow-up to
assess arterial patency, restenosis rate and global left ventric-
ular functions.
Statistical analysis. Continuous data are expressed as
mean value  SD. The statistical signiﬁcance of the changes in
ejection fraction, heart rate, systolic blood pressure and wall
motion score index was tested using two-way, repeated mea-
sures analysis of variance (ANOVA) with the Tukey post hoc
test. Sensitivity, speciﬁcity, predictive values and accuracy were
evaluated according to standard deﬁnitions. Comparisons of
proportions were performed using the chi-square test. A value
of p  0.05 was considered statistically signiﬁcant.
Results
Clinical and angiographic patient characteristics. The
ECG location of acute myocardial infarction was anterior in 24
patients and inferior in 6. The infarct-related artery was the left
anterior descending coronary artery in 24 patients, the right
coronary artery in 3 and the circumﬂex artery in 3. Coronary
lesions involved a single vessel in 17 patients, two vessels in 10
and three vessels in 3. The echocardiographic left ventricular
ejection fraction on admission was 38  8%. All patients
achieved successful coronary reperfusion with 30% residual
stenosis and TIMI ﬂow grade 3. After 1 month all patients had
a patent infarct-related artery and none exhibited signiﬁcant
restenosis (50% lumen diameter narrowing).
Safety. No patient showed hemodynamic derangement,
complex ventricular or supraventricular arrhythmias or aug-
mentation of chest pain during or immediately after myocar-
dial contrast echocardiography. Furthermore, intracoronary
injection of the contrast medium did not produce further
changes in the ST-T segment on a 12-lead ECG continuously
monitored during and after contrast echocardiography. Simi-
larly, no complication occurred during dobutamine infusion.
Heart rate increased from 83  13 beats/min at rest to 99  15
beats/min at peak dobutamine infusion (p  0.05), and systolic
blood pressure increased from 119  11 mm Hg at rest to
132  14 mm Hg at peak dobutamine infusion (p  0.05).
Myocardial perfusion in the acute stage. Myocardial per-
fusion by contrast echocardiography was evaluated in a total of
180 segments. During coronary occlusion myocardial perfusion
defects were observed in all patients and involved 72 segments
(40% of explored segments). Shortly after infarct-related ar-
tery recanalization, the majority of patients (26 of 30) showed
myocardial reperfusion of previously ischemic segments. Of 72
segments within the area at risk, 63 were reperfused; of these,
41 (65%) showed homogeneous contrast effect (score 1) and
22 (35%) a partial enhancement pattern (score 0.5). Despite
successful angioplasty, myocardial perfusion defects were still
present in four patients (no-reﬂow phenomenon) and involved
nine segments (12% of the segments within the area at risk).
Effects of myocardial reperfusion on left ventricular func-
tion. According to ANOVA there was a signiﬁcant effect of
the grouping factor (reﬂow vs. no-reﬂow: F  8.34, degrees of
freedom [df]  28, p  0.01). No signiﬁcant effect was
observed for the repeated measures factor (baseline vs. follow-
up: F  1.99, p  0.16), nor for the interaction (F  1.58, p 
0.21). In the 26 patients with myocardial reperfusion after
coronary angioplasty, left ventricular ejection fraction by two-
dimensional echocardiography signiﬁcantly improved from the
baseline to the follow-up study (39  8% vs. 48  12%, p 
0.006), although no improvement was noted in the four
patients with the no-reﬂow phenomenon (30  7% vs. 31 
15%, p  0.99). With regard to wall motion score index in the
area at risk, two-way ANOVA showed a signiﬁcant reﬂow
effect (F  4.75, p  0.004) and an even more signiﬁcant
repeated measures effect (F  5.63, p  0.024). However,
there was no signiﬁcant interaction between the two factors
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(F  2.48, p  0.12). The reperfused patients showed a
signiﬁcant reduction in the wall motion score index in the area
at risk from the baseline (before angioplasty) to the follow-up
studies (2.35  0.5 vs. 2  0.6, p  0.0005), although no
signiﬁcant difference was noted among the patients with the
no-reﬂow phenomenon (2.63  0.1 vs. 2.55  0.2, p  0.97)
(Fig. 1).
Prediction of regional functional recovery by myocardial
contrast echocardiography and dobutamine echocardiogra-
phy. Functional recovery at follow-up was observed in 14
(54%) of the 26 patients with myocardial reperfusion and in
none of the 4 patients with the no-reﬂow phenomenon. All of
the 14 dobutamine responders and only 1 of the 16 nonre-
sponders showed a late improvement in left ventricular re-
gional function. Thus, the sensitivity of myocardial contrast
echocardiography and dobutamine echocardiography for pre-
dicting late functional improvement in individual patients was
100% and 93%, and speciﬁcity 25% and 100%, respectively.
Of the 63 reperfused segments (score 1 or 0.5), shortly after
coronary angioplasty, 26 (41%) showed an improvement in
wall motion score after 1 month, whereas 37 did not. In
contrast, only 1 of the 9 nonreperfused segments showed a late
functional recovery. Of the 41 segments with normal perfusion
(score 1), 18 improved at 1 month, whereas 23 did not. Finally,
functional recovery occurred only in 9 of 31 segments with
partial (score 0.5) or no reﬂow (score 0).
Abnormal wall motion was observed before dobutamine
echocardiography in all 72 segments within the area at risk, of
which 28 improved during dobutamine infusion. At 1 month,
functional recovery occurred in 24 (86%) of 28 segments with
contractile reserve, and in 3 (7%) of 44 segments without
contractile reserve. According to ANOVA there was a signif-
icant grouping factor effect (dobutamine responders vs. non-
responders: F  13.7, df  28, p  0.001) and a very high
within-group repeated measures effect (baseline vs. follow-up:
F  58.5, p  0.000001). Also, the relation between the two
effects was highly signiﬁcant (F  32.1, p  0.00005). Total
wall motion score index signiﬁcantly decreased from baseline
to follow-up studies in dobutamine responders (2.34  0.4 vs.
1.7  0.4, p  0.002), although remained unchanged in
dobutamine nonresponders (2.48  0.2 vs. 2.4  0.2, p  0.48)
(Fig. 2).
Table 1 gives the sensitivities, speciﬁcities, predictive values
and accuracy of myocardial contrast echocardiography and
dobutamine echocardiography for predicting late functional
recovery of individual segments. The two methods had similar
sensitivities and negative predictive values in predicting func-
tional recovery; however, contractile reserve by dobutamine
echocardiography had a signiﬁcantly better speciﬁcity (91% vs.
18%, p  0.001), positive predictive value (86% vs. 41%, p 
0.001) and overall accuracy (90% vs. 47%, p  0.001) than
perfusion by myocardial contrast echocardiography. When
data were adjusted to take into consideration only the homo-
geneous pattern of contrast enhancement as the threshold
value, speciﬁcity increased to 49%, but sensitivity decreased to
67%. When all the dysfunctional segments in each selected
echocardiographic view at the time of coronary occlusion—
independently of myocardial perfusion—were included in the
Figure 1. Plots of wall motion score index (WMSI) in the area at risk
in the acute and chronic stages of myocardial infarction in patients
with (open circles) and without residual contrast defects (solid circles).
Figure 2. Plots of area at risk wall
motion score index (WMSI) at base-
line and at 1-month follow-up in
dobutamine responders (left) and
nonresponders (right).
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analysis, sensitivity and speciﬁcity for myocardial contrast
echocardiography and dobutamine echocardiography were,
respectively, 97% and 13% and 82% and 88%.
Correlation between contractile reserve and myocardial
perfusion. Of the 72 dysfunctional segments in the area at
risk, 12 were hypokinetic, 56 were akinetic and 4 were dyski-
netic. Dysfunctional segments were more likely to exhibit
perfusion than contractile reserve (88% vs. 39%, p  0.001).
The two techniques were concordant in 31 segments (43%), so
perfusion and contractile reserve were either present or both
absent. Concordance was higher in hypokinetic segments
(75%) than in akinetic or dyskinetic segments (35%). The dis-
agreement between the two techniques was related primarily to
the ﬁnding of segments considered viable by contrast echocardi-
ography that did not show contractile reserve by dobutamine
echocardiography (39 segments, or 54% of the total number of
segments with rest wall motion abnormalities) (Fig. 3).
Myocardial perfusion in the chronic stage. Data on myo-
cardial perfusion by contrast echocardiography at 1 month
after the index infarction were available in 18 patients. All
these patients had normal (score 1) myocardial perfusion after
angioplasty. Nevertheless, in three patients a contrast defect
reappeared at the follow-up study, involving a total of 7
segments. All these segments were unresponsive to dobut-
amine infusion and none showed an improvement in wall
motion at follow-up.
Reproducibility. On when myocardial contrast echocardi-
ography results were interpreted, there was complete agree-
ment between the three observers in 168 of 180 segments
(93%), and in the remaining 12 segments, a consensus was
reached. Similarly, intraobserver agreement was good (96%).
Intraobserver and interobserver variabilities were also assessed
for dobutamine echocardiography. The two observers concor-
dantly scored 92% (66 of 72) of the dissynergic segments within
the area at risk as having dobutamine-responsive or
dobutamine-unresponsive wall motion. Intraobserver variabil-
ity was assessed by one reader (G.C.). Segments were concor-
dantly scored as dobutamine responsive or unresponsive in
94% (68 of 72).
Discussion
Myocardial contrast echocardiography is gaining interest as
a promising method of assessing myocardial viability after
acute myocardial infarction. Normal microvascular perfusion is
present in regions of viable myocardium, whereas regions of
necrosis do not demonstrate microvascular perfusion or show
poor perfusion. The assessment of viability by use of this
technique has been previously demonstrated in postinfarction
patients by several investigators (10–12). However, a direct
comparison of myocardial contrast echocardiography with
other validated methods such as dobutamine echocardiogra-
phy for assessing myocardial viability in patients with acute
myocardial infarction, in whom anterograde ﬂow is fully re-
stored without signiﬁcant residual stenosis, is still missing. In
this setting, when myocardial necrosis coexists with postisch-
emic myocardial dysfunction and no ﬂow-limiting residual
stenosis, dobutamine echocardiography has the potential to
accurately assess the extent of viable myocardium (9). Similar
to the results reported by Ito et al. in 1992 (10) and more
recently by others investigators (18), we found that myocardial
segments can show residual perfusion defects despite restora-
tion of anterograde ﬂow, indicating that angiographically suc-
cessful coronary recanalization, even with a TIMI ﬂow grade 3,
does not necessarily imply adequate myocardial perfusion. In
addition, patients with early no-reﬂow exhibit a poor func-
tional recovery at follow-up. However, acutely reperfused
segments at myocardial contrast echocardiography often did
not demonstrate contractile reserve at 3 days; such segments
generally did not show late functional improvement. Thus, the
major new ﬁndings of the present study are that contrast
enhancement shortly after reﬂow does not necessarily imply
regional functional recovery in the chronic stage and that
contractile reserve elicited by dobutamine echocardiography 3
days after acute myocardial infarction is more accurate than
early perfusion, as assessed by myocardial contrast echocardi-
Figure 3. Pie charts showing concordance between myocardial perfu-
sion by contrast echocardiography (MCE) and contractile reserve by
dobutamine echocardiography (DE). DE POS (DE NEG)  presence
(absence) of contractile reserve during low-dose dobutamine infusion;
MCE (MCE) patients with (without) reﬂow after infarct-related
artery recanalization.
Table 1. Comparative Sensitivity, Speciﬁcity, Predictive Values and Accuracy of Perfusion by Myocardial Contrast Echocardiography and






MCE (score 0.5–1) 25/27 (96%) 8/45 (18%) 25/63 (41%) 8/9 (89%) 34/72 (47%)
MCE (score 1) 18/27 (67%) 22/45 (49%) 18/41 (44%) 22/31 (71%) 40/72 (56%)
DE 24/27 (89%) 41/45 (91%)* 24/28 (86%)* 41/44 (93%) 65/72 (90%)*
*p  0.001. Data presented are number (%) of segments. DE  dobutamine echocardiography; MCE  myocardial contrast echocardiography.
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ography, for predicting functional recovery in patients in whom
reperfusion is achieved by means of primary coronary angio-
plasty.
Microvascular integrity, contractile reserve and myocar-
dial viability. Cardiac imaging techniques that evaluate myo-
cardial viability on the basis of myocardial perfusion, cell
membrane integrity, contractile reserve and metabolic activity
are being used increasingly in the clinical arena (4). Each of
these techniques explores one aspect of viability, and funda-
mental differences may exist between viability expressed by one
method with respect to others (19). Thus, the ﬁnding of the
present study, that only half of the segments with homoge-
neous contrast enhancement had preserved contractile reserve
and demonstrated improvement at late follow-up, should not
be surprising. There are several possible explanations: 1) The
infarct area may be a mixing of islands of viable and necrotic
myocites (20). In this scenario it is possible that perfusion,
although to a lesser extent than normal regions, may be
detected despite functional integrity that is precluded by an
insufﬁcient number of viable myocites. This hypothesis might
be suggested by the patchy pattern of contrast enhancement,
which appeared to be a less speciﬁc marker of myocardial
viability than the homogeneous pattern. 2) Because of hyper-
emia during the early hours of reperfusion (21–23), myocardial
contrast echocardiography may underestimate infarct size and
overestimate myocardial salvage (24). This may be particularly
true when the residual stenosis within the infarct-related artery
is not severe enough to attenuate hyperemic ﬂow, as in our
series. The use of an exogenously administered coronary
vasodilator, such as dipyridamole, to unmask the reduced
microvascular reserve of the infarcted tissue has been recently
proposed (25); however, this approach may be unpractical or
even unsafe during coronary angioplasty performed for the
treatment of an evolving acute myocardial infarction. Third, a
temporal dissociation between microvascular and cellular dam-
age may exist (26,27), and recent studies have suggested that
late evaluation of myocardial perfusion by contrast echocardi-
ography correlates with late functional recovery more closely
than myocardial perfusion evaluated shortly after reperfusion
(28,29). The dynamic nature of myocardial perfusion is further
conﬁrmed by the present study, where perfusion defects reap-
peared 1 month after coronary reﬂow, despite the absence of
coronary restenosis.
One may speculate that reperfusion injury and the time
delay from the cell death to the destruction of capillary
network may be a possible explanation for the absence of
contractile reserve evaluated in a relatively late phase after
reperfusion and the lack of recovery of regional function at
follow-up. Finally, we chose the recovery of contractility as the
primary end point because of its prognostic relevance; how-
ever, we cannot exclude that microvascular integrity also plays
a role in the clinical outcome by a different mechanism, such as
prevention of ventricular remodeling.
Study limitations. Several potential limitations of the
present study should be acknowledged. The number of
patients was relatively small, and dobutamine and contrast
echocardiography were not performed simultaneously.
Moreover, we did not compare myocardial contrast echo-
cardiography with other accepted methods of assessing
myocardial viability. However, dobutamine echocardiogra-
phy has been shown to compare favorably with both
thallium-201 scintigraphy and positron emission tomogra-
phy both in acute and chronic ischemic heart disease
(5,30,31). The assessment of the risk area during coronary occlu-
sion requires injections into both the coronary ostia, which were
not performed in six patients. In these patients collateral ﬂow
distal to the occluded infarct-related artery was not demonstrated
during myocardial contrast echocardiography, and hence the
functional risk area was likely overestimated (32).
The analysis of contrast echocardiographic images was
performed only in one cross-sectional view; thus, the analysis
of functional recovery was based on a small number of
segments relative to a total number of dysfunctional segments.
This may explain the substantial improvement in left ventric-
ular function despite the small number of segments within the
area at risk showing functional improvement at follow-up. The
performance of dobutamine echocardiography was tested in a
setting where no patient had signiﬁcant residual stenosis.
Therefore, the results of the present study may not be directly
applicable to clinical situations where residual stenosis is
present. An additional potential limitation of this study is that
follow-up echocardiography was performed 1 month after
coronary angioplasty, whereas recent studies show that left
ventricular function can improve in a substantial number of
segments several months after an acute infarction (33). Finally,
the analysis of regional function was semiquantitative. How-
ever, this qualitative approach has been largely adopted for
clinical studies with stress echocardiography in ischemic heart
disease (34). Similarly, our method of assessing myocardial
contrast effect was subjective and only one section was ex-
plored; a quantitative approach was not possible in all patients
given the quality of the studies, which were obtained during
cardiac catheterization with the patients in the supine position,
and the current limitations of the technique. These factors,
along with the complexity of the protocol, may have affected
the feasibility of the study.
Conclusions. Our data indicate that preserved myocardial
perfusion is a prerequisite for myocardial viability after a
reperfused myocardial infarction. In fact, functional recovery
of the postinfarction reperfused myocardium is observed only
when adequate tissue ﬂow is restored, which is highly improb-
able in patients with the no-reﬂow phenomenon. However,
contrast enhancement shortly after reperfusion does not nec-
essarily imply a late functional improvement. In the setting of
acute myocardial infarction successfully treated with primary
coronary angioplasty without residual stenosis limiting hyper-
emic ﬂow, contractile reserve by dobutamine echocardiogra-
phy appears to be more accurate than myocardial perfusion by
contrast echocardiography for predicting reversible regional
myocardial dysfunction.
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